Connect with us

Business

FDA Approved Biogen Alzheimer’s Drug Despite Some Staff Concerns – The Wall Street Journal

The agency has faced criticism for approving the drug, Aduhelm, without clear proof it works

Published

on

Article feature image
ADVERTISEMENT

The U.S. Food and Drug Administration approved the first new Alzheimers drug in decades over the objection of agency statisticians who said there was insufficient evidence to support approval, according to newly released internal memos.
In the internal…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
The FAA Changed Its Definition of ‘Astronaut’ on the Same Day Jeff Bezos Went to Space – Gizmodo
Article feature image
AXP Stock Rises To High As American Express Earnings Spikes 866% – Investor’s Business Daily
Article feature image
10 Wind Energy Stock Photos That Make Me Extremely Uncomfortable – Gizmodo